We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,646

Government’s Case Dismissed Due to Inability to Allege False Claims With Particularity
  • McDermott Will & Emery
  • USA
  • January 26 2016

The United States District Court for the Middle District of Florida recently dismissed the Government’s False Claims Act case against Liberty


Shall means shall . . . unless it doesn’t
  • McDermott Will & Emery
  • USA
  • August 27 2015

Addressing issues of first impression related to the Biologics Price Competition and Innovation Act of 2009 (BPCIA), which the U.S. Court of Appeals


OIG’s 2016 Work Plan: mixed results for 2015 and new data mining and policy efforts in 2016
  • McDermott Will & Emery
  • USA
  • November 23 2015

The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) annual release of a new Work Plan both summarizes the


Adventist Health System settles Stark Law & FCA matters
  • McDermott Will & Emery
  • USA
  • September 23 2015

Adventist Health System (Adventist) entered into a settlement agreement with the United States and with the states of Florida and North Carolina on


21st Century Cures Act: Small Employer Changes under the Affordable Care Act
  • McDermott Will & Emery
  • USA
  • December 16 2016

President Obama has signed the 21st Century Cures Act, Pub. L. No. 114-225 (Dec. 13, 2016). As we previously mentioned, the new legislation permits


Post-DMA, Federal Court of Appeals broadly interprets jurisdictional limitations of Anti-Injunction Act
  • McDermott Will & Emery
  • USA
  • September 3 2015

Earlier this month, the United States Court of Appeals for the D.C. Circuit held in Florida Bankers Ass'n v. U.S. Dep't of the Treasury, No. 14-5036


Fetal DNA test cannot give birth to a patent
  • McDermott Will & Emery
  • USA
  • July 29 2015

Addressing the issue of patent eligibility of a pre-natal testing invention, the U.S. Court of Appeals for the Federal Circuit unanimously affirmed


OIG Issues New Exclusion and CIA Guidance
  • McDermott Will & Emery
  • USA
  • April 28 2016

On April 18, 2016, Inspector General Daniel R. Levinson announced the publication of updated guidance on how the Office of Inspector General (OIG


FTC comment: Minnesota law requiring public disclosure of health care contract data increases risk of anticompetitive behavior
  • McDermott Will & Emery
  • USA
  • July 14 2015

On June 29, 2015, the Federal Trade Commission (FTC) responded to a request for comment from two Minnesota state legislators concerning recently


Condition of payment limitation on implied certification cases is alive and well in the D.C. Circuit
  • McDermott Will & Emery
  • USA
  • July 14 2015

To the extent there was ever any doubt about the vitality the "condition of payment" limitation on "implied certification" False Claims Act (FCA